Join us for an insightful ReproTalk where leading researchers will explore how one of the world’s most commonly used over-the-counter medicines may influence reproductive health. The event will highlight the latest findings from studies, offering a deeper understanding of potential risks and mechanisms behind paracetamol exposure during critical stages of development.
This ReproTalk offers a unique opportunity to engage with experts, ask questions, and expand your understanding of how everyday medications can impact reproductive health.
The afternoon begins with coffee, fruit, and networking, followed by two scientific sessions and a panel discussion:
| 16:00–16:30 | Sandwich and Networking |
| 16:30–16:45 | Introduction to ReproYoung, the upcoming ReproYoung Conference, and future talks |
| 16:45–17:30 | Session 1: “Paracetamol and Adverse Health Effects – Truth or Politics?” Speaker: Professor David Møbjerg Kristensen, Department of Science and Environment, Roskilde University, and Department of Growth and Reproduction, Rigshospitalet |
| 17:30–17:45 | Break with coffee and cake |
| 17:45–18:30 | Session 2: “Ovarian Function in Healthy Infant Girls – Associations with Prenatal Paracetamol Exposure and Future Ovarian Activity” Speaker: Margit Bistrup Fischer, MD, PhD, Department of Growth and Reproduction, Rigshospitalet |
| 18:30–19:00 | Panel debate and Q&A |
Organized by
